42 related articles for article (PubMed ID: 32158967)
21. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
22. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
23. BAP1 hereditary cancer predisposition syndrome: a case report and review of literature.
Klebe S; Driml J; Nasu M; Pastorino S; Zangiabadi A; Henderson D; Carbone M
Biomark Res; 2015; 3():14. PubMed ID: 26140217
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
[TBL] [Abstract][Full Text] [Related]
25. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
26. BAP1 protein is a progression factor in malignant pleural mesothelioma.
Arzt L; Quehenberger F; Halbwedl I; Mairinger T; Popper HH
Pathol Oncol Res; 2014 Jan; 20(1):145-51. PubMed ID: 23963927
[TBL] [Abstract][Full Text] [Related]
27. Germline BAP1 mutations predispose to renal cell carcinomas.
Popova T; Hebert L; Jacquemin V; Gad S; Caux-Moncoutier V; Dubois-d'Enghien C; Richaudeau B; Renaudin X; Sellers J; Nicolas A; Sastre-Garau X; Desjardins L; Gyapay G; Raynal V; Sinilnikova OM; Andrieu N; Manié E; de Pauw A; Gesta P; Bonadona V; Maugard CM; Penet C; Avril MF; Barillot E; Cabaret O; Delattre O; Richard S; Caron O; Benfodda M; Hu HH; Soufir N; Bressac-de Paillerets B; Stoppa-Lyonnet D; Stern MH
Am J Hum Genet; 2013 Jun; 92(6):974-80. PubMed ID: 23684012
[TBL] [Abstract][Full Text] [Related]
28. BAP1 loss defines a new class of renal cell carcinoma.
Peña-Llopis S; Vega-Rubín-de-Celis S; Liao A; Leng N; Pavía-Jiménez A; Wang S; Yamasaki T; Zhrebker L; Sivanand S; Spence P; Kinch L; Hambuch T; Jain S; Lotan Y; Margulis V; Sagalowsky AI; Summerour PB; Kabbani W; Wong SW; Grishin N; Laurent M; Xie XJ; Haudenschild CD; Ross MT; Bentley DR; Kapur P; Brugarolas J
Nat Genet; 2012 Jun; 44(7):751-9. PubMed ID: 22683710
[TBL] [Abstract][Full Text] [Related]
29. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations in BAP1 predispose to melanocytic tumors.
Wiesner T; Obenauf AC; Murali R; Fried I; Griewank KG; Ulz P; Windpassinger C; Wackernagel W; Loy S; Wolf I; Viale A; Lash AE; Pirun M; Socci ND; Rütten A; Palmedo G; Abramson D; Offit K; Ott A; Becker JC; Cerroni L; Kutzner H; Bastian BC; Speicher MR
Nat Genet; 2011 Aug; 43(10):1018-21. PubMed ID: 21874003
[TBL] [Abstract][Full Text] [Related]
31. Germline BAP1 mutations predispose to malignant mesothelioma.
Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
[TBL] [Abstract][Full Text] [Related]
32. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Bott M; Brevet M; Taylor BS; Shimizu S; Ito T; Wang L; Creaney J; Lake RA; Zakowski MF; Reva B; Sander C; Delsite R; Powell S; Zhou Q; Shen R; Olshen A; Rusch V; Ladanyi M
Nat Genet; 2011 Jun; 43(7):668-72. PubMed ID: 21642991
[TBL] [Abstract][Full Text] [Related]
33. Frequent mutation of BAP1 in metastasizing uveal melanomas.
Harbour JW; Onken MD; Roberson ED; Duan S; Cao L; Worley LA; Council ML; Matatall KA; Helms C; Bowcock AM
Science; 2010 Dec; 330(6009):1410-3. PubMed ID: 21051595
[TBL] [Abstract][Full Text] [Related]
34. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.
Machida YJ; Machida Y; Vashisht AA; Wohlschlegel JA; Dutta A
J Biol Chem; 2009 Dec; 284(49):34179-88. PubMed ID: 19815555
[TBL] [Abstract][Full Text] [Related]
35. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
36. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Ventii KH; Devi NS; Friedrich KL; Chernova TA; Tighiouart M; Van Meir EG; Wilkinson KD
Cancer Res; 2008 Sep; 68(17):6953-62. PubMed ID: 18757409
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1.
Julien E; Herr W
EMBO J; 2003 May; 22(10):2360-9. PubMed ID: 12743030
[TBL] [Abstract][Full Text] [Related]
38. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.
Freedland SJ; Sutter ME; Dorey F; Aronson WJ
Urology; 2003 Feb; 61(2):365-9. PubMed ID: 12597949
[TBL] [Abstract][Full Text] [Related]
39. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
[TBL] [Abstract][Full Text] [Related]
40. BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma.
Oh H; Lee YJ; Kang SG; Ahn B; Kim E; Chae YS; Lee Y; Lee JH; Kim CH
Investig Clin Urol; 2020 Mar; 61(2):166-172. PubMed ID: 32158967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]